Skip to main content

Vikram Karnani

Equibles does not estimate personal net worth.

Get an email with a short summary when Dyne Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get DYN alerts

About Vikram Karnani

Vikram Karnani is recorded as Board Member at Dyne Therapeutics, Inc. (DYN) since December 22, 2025. Dyne Therapeutics, Inc. reported in an 8-K filed December 23, 2025 that Vikram Karnani was appointed Class II director, effective December 22, 2025. Dyne Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dyne Therapeutics, Inc. includes John Cox (CEO and Board Member), John G. Cox (CEO and Board Member), Josh Brumm (CEO) and 4 others.

“On December 22, 2025, the Board of Directors (the "Board") of Dyne Therapeutics, Inc. (the "Company"), upon recommendation from the Nominating and Corporate Governance Committee of the Board, elected Vikram Karnani as a Class II director to serve on the Board until the Company's 2028 Annual Meeting of Stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal.”
Dyne Therapeutics, Inc. Form 8-K, filed December 23, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Dyne Therapeutics, Inc.

Recent activity